This month, Alise Pharma officially surpassed 100,000 unique customers -- a milestone that felt distant when we shipped our first orders from a modest warehouse just three years ago. This number represents more than a metric on a dashboard. It represents 100,000 individuals who have placed their trust in our products, our science, and our promise to deliver pharmaceutical-grade supplements without compromise.

We want to take this moment to reflect on the journey that brought us here, share some of the data that defines our customer relationships, and look ahead at what comes next for Alise Pharma.

The Growth Journey

Alise Pharma launched in early 2022 with a focused catalog of three products: our flagship Omega-3 Ultra, a high-potency Vitamin D3+K2 formula, and a pharmaceutical-grade magnesium glycinate. We made a deliberate choice to start small rather than flood the market with a large product line. Our philosophy was simple -- do fewer things, but do them exceptionally well.

That approach resonated. Within six months, word-of-mouth referrals and organic search traffic drove our first 10,000 customers without a single paid advertisement. Customers were drawn to the transparency of our ingredient sourcing, the availability of batch-level Certificates of Analysis, and the noticeable quality difference compared to mass-market alternatives.

By the end of 2023, we had expanded to 12 products and crossed 40,000 customers. The launch of our subscription program in early 2024 accelerated growth further, providing customers with a convenient way to maintain their supplement routines while saving 15% on every order. In 2025, the addition of our peptide and nootropic lines brought us to the 100,000 mark -- a pace of growth that has consistently exceeded our internal projections.

Customer Satisfaction by the Numbers

Reaching 100,000 customers is meaningful, but the quality of those relationships matters far more than the quantity. We track several key metrics that help us understand how well we are serving the people who trust us with their health.

Our Net Promoter Score (NPS) currently stands at 78, placing us well above the supplement industry average of approximately 38. NPS measures how likely customers are to recommend a brand to others, and scores above 70 are considered world-class across any industry. This score is derived from post-purchase surveys sent to a randomized sample of customers each month.

Our average product rating across all SKUs is 4.7 out of 5.0 stars, based on over 45,000 verified customer reviews. We publish every review -- positive and negative -- without filtering or editorial intervention. Our customer support team responds to every review rated three stars or below within 24 hours, and we use that feedback to drive product and process improvements.

Customer support resolution time averages under four hours for email inquiries and under two minutes for live chat. We maintain a first-contact resolution rate of 92%, meaning the vast majority of customer issues are resolved without requiring follow-up interactions.

Repeat Purchase Rates and Loyalty

One of the metrics we are most proud of is our repeat purchase rate. Within six months of their first order, 64% of Alise Pharma customers make a second purchase. By the twelve-month mark, that figure rises to 72%. These numbers are significantly above the supplement industry average of approximately 30-40% for twelve-month repeat purchases.

Our subscription program has been a major driver of retention. Currently, 41% of our active customers are on a subscription plan, with an average subscription duration of 9.3 months. The monthly churn rate for subscribers is just 4.2%, reflecting the consistency of our product quality and the value proposition of the subscription model.

Average order value has also grown steadily, from $47 at launch to $68 today, driven primarily by customers adding products to their routines over time rather than by price increases. The average Alise Pharma customer now purchases 2.8 different products, up from 1.4 at the time of our first anniversary.

What Comes Next

Reaching 100,000 customers gives us the scale and the confidence to invest aggressively in the next phase of Alise Pharma's growth. Over the coming year, we have several major initiatives underway.

We are expanding our product catalog with new entries in the peptide, nootropic, and sports performance categories -- including formulations that have been in development for over 18 months. We are also investing in personalization technology that will allow customers to receive tailored supplement recommendations based on their health goals, lifestyle factors, and biomarker data.

On the distribution side, we recently announced expansion into 15 international markets, bringing our products to customers outside the United States for the first time. We are also exploring partnerships with select brick-and-mortar retailers who share our commitment to quality and transparency.

Internally, we are doubling the size of our quality assurance team and investing in new laboratory equipment that will allow us to bring certain testing capabilities in-house, reducing turnaround times while maintaining the rigor of our third-party testing program.

Thank You to Our Customers

None of this would be possible without the customers who chose to trust Alise Pharma -- many of them long before we had brand recognition or industry awards to point to. Your willingness to try a new brand, your honest feedback, your referrals to friends and family, and your patience as we navigated the inevitable growing pains of a young company have been the foundation of everything we have built.

We do not take that trust for granted. Every product we develop, every batch we test, and every customer interaction we have is guided by a simple question: are we earning the trust that has been placed in us? At 100,000 customers and counting, we remain as committed to that standard as we were on day one.

Thank you for being part of the Alise Pharma community. The best is yet to come.